Item 7.01		Regulation FD Disclosure.

On December 10, 2007, Replidyne issued a press release regarding an operational restructuring to align resources with strategic priorities. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.

In accordance with General Instruction B.2. of Form 8-K, the information presented under this Item 7.01 and attached as Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing.

Item 9.01		Financial Statements and Exhibits.

(c) Exhibits.

99.1		Press Release, dated December 10, 2007, Entitled “Replidyne Provides Strategic Update - Initiatives Include Restructuring and Pipeline Prioritization.”

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

EXHIBIT INDEX

Exhibit No.		Description
99.1		Press Release, dated December 10, 2007, Entitled “Replidyne Provides Strategic Update - Initiatives Include Restructuring and Pipeline Prioritization.”